Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers various financial products and investment consultation services. The Investment Management segment offers investment trust management, discretionary investment services, and investment funds. The Wholesale segment is involved in the sale, trading, agency execution, and market-making of fixed income and equity products, as well as structured financing and solutions. This segment also engages in underwriting various securities and other financial instruments, such as various classes of shares, convertible and exchangeable securities, investment grade and high yield debts, sovereign and emerging market debts, structured securities, and other securities; arranging private placements, as well as other capital raising activities; and provision of financial advisory services on business transactions comprising mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was incorporated in 1925 and is headquartered in Tokyo, Japan.

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings Inc Adr (($NMR)) has held its Q4 earnings call. Read on for the main highlights of the call. Nomura Holdings delivered a broadly up...

Nomura Earnings Call: Record Year, Softer Quarter

Investors following the securities lawsuit against Neumora Therapeutics (NMRA) are facing another procedural turn after a federal judge denied the ...

Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint

Nova ( ($NVMI) ) just unveiled an announcement. Nova announced on May 18, 2026, that its senior management team will engage with investors at sever...

Nova Plans Series of Investor Conference Appearances in Late May and Early June 2026

In a report released on May 14, Fernando Garcia from RBC Capital maintained a Hold rating on SNAM S.p.A., with a price target of €6.40. The company...

RBC Capital Keeps Their Hold Rating on SNAM S.p.A. (0NQP)

Nova ( ($NVMI) ) has shared an update. On May 14, 2026, Nova Ltd. filed a Form 6-K announcing its 2026 annual general meeting of shareholders, sche...

Nova Sets June 18, 2026 Annual Meeting to Vote on Board Slate, CEO Pay and Auditor Reappointment

Banca Akros analyst downgraded SNAM S.p.A. to a Hold today and set a price target of €6.60. In a report released today, Kepler Capital also downgra...

Banca Akros downgrades SNAM S.p.A. (0NQP) to a Hold

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mettler-Toledo (MTD) and Neumora Therapeutics, Inc. (NMRA). Mettl...

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (MTD) and Neumora Therapeutics, Inc. (NMRA)

Cantor Fitzgerald analyst Matthew Prisco maintained a Buy rating on Nova today and set a price target of $525.00. Prisco covers the Technology sect...

Cantor Fitzgerald Reaffirms Their Buy Rating on Nova (NVMI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Siemens Healthineers AG (SEMHF) and Neumora Therapeu...

Analysts’ Top Healthcare Picks: Siemens Healthineers AG (SEMHF), Neumora Therapeutics, Inc. (NMRA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cullinan Management (CGEM) and Neumora Therapeutics,...

Analysts’ Top Healthcare Picks: Cullinan Management (CGEM), Neumora Therapeutics, Inc. (NMRA)

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Camden Property (CPT), Newmark Group (NMRK) and LXP Industrial T...

Market Cap	$23.65B	P/E Ratio	10.22
52W High	$9.58	52W Low	$5.77
Div Yield	34.8%	Payout Ratio	49.6%
EPS Growth 3Y	N/A	52W Position	60.3%
Overall Score	61	Value Score	100
Quality Score	44	Technical Score	40

EPS Current Est	$0.79	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NMR	$8.07	-0.49%	1.55M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NMR	$8.07	-0.5%	1.55M
3
4
5
6

NMR

NMR

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Nomura Holdings Inc ADR American Depositary Shares Data in Excel

Get Nomura Holdings Inc ADR American Depositary Shares Data in Excel